HPV16 variant lineage, clinical stage, and survival in women with invasive cervical cancer

Infectious Agents and Cancer

Volumn 6, Issue 1, 2011, Pages

  Zuna, Rosemary E ^a   Tuller, Erin ^a,c   Wentzensen, Nicolas ^b   Mathews, Cara ^a   Allen, Richard A ^a   Shanesmith, Rebecca ^a,d   Dunn, S Terence ^a   Gold, Michael A ^a,e   Wang, Sophia S ^b,f   Walker, Joan ^a   Schiffman, Mark ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c University of Missouri   (United States)

^d TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^f CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

cervical neoplasms; HPV16 variants; human papillomavirus 16

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; DNA SEQUENCE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

EID: 80054997779     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-6-19     Document Type: Article

References (25)

1. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM, Int J Cancer 2010 128 927 935
2. Classification of papillomaviruses. de Villiers E-M, Fauquet C, Broker TR, Bernard H-U, zur Hausen H, Virology 2004 324 17 27 10.1016/j.virol.2004.03. 033 15183049 (Pubitemid 38737395)
3. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. Yamada T, Wheeler C, Halpern A, Stewart A, Hildesheim A, Jenison S, J Virol 1995 69 7743 7753 7494284
4. Phylogenetic analysis of 48 papillomavirus types and 28 subtypes and variants: a showcase for the molecular evolution of DNA viruses. Chan SY, Bernard HU, Ong CK, Chan SP, Hofmann B, Delius H, J Virol 1992 66 5714 5725 1326639
5. Human papillomavirus type 16 variants and risk of cervical cancer. Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez A, Bratti MC, Sherman ME, Scarpidis U, Lin QQ, Terai M, Bromley RL, Buetow K, Apple RJ, Burk RD, J Natl Cancer Inst 2001 93 315 318 10.1093/jnci/93.4.315 11181779 (Pubitemid 32219819)
6. Risk for High-Grade Cervical Intraepithelial Neoplasia Associated with Variants of Human Papillomavirus Types 16 and 18. Xi LF, Koutsky LA, Hildesheim A, Galloway DA, Wheeler CM, Winer RL, Ho J, Kiviat NB, Cancer Epidemiol Biomarkers Prev 2007 16 4 10 10.1158/1055-9965.EPI-06-0670 17220325 (Pubitemid 46174256)
7. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, Franco EL, J Gen Virol 2000 81 2959 2968 11086127 (Pubitemid 32000643)
8. Asian-American Variants of Human Papillomavirus 16 and Risk for Cervical Cancer: a Case-Control Study. Berumen J, Ordonez RM, Lazcano E, Salmeron J, Galvan SC, Estrada RA, Yunes E, Garcia-Carranca A, Gonzalez-Lira G, Madrigal-de la Campa A, J Natl Cancer Inst 2001 93 1325 1330 10.1093/jnci/93.17.1325 11535707 (Pubitemid 32910573)
9. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Burk RD, Terai M, Gravitt PE, Brinton LA, Kurman RJ, Barnes WA, Greenberg MD, Hadjimichael OC, Fu L, McGowan L, Mortel R, Schwartz PE, Hildesheim A, Cancer Res 2003 63 7215 7220 14612516 (Pubitemid 37413460)
10. HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix. Quint KD, de Koning MNC, van Doorn L-J, Quint WGV, Pirog EC, Gynecol Oncol 2010 117 297 301 10.1016/j.ygyno.2010. 02.003 20207397
11. Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. Zuna RE, Moore WE, Shanesmith RP, Dunn ST, Wang SS, Schiffman M, Blakey GL, Teel T, Int J Cancer 2009 125 2609 2613 10.1002/ijc.24706 19569178
12. A Population-Based Prospective Study of Carcinogenic Human Papillomavirus Variant Lineages, Viral Persistence, and Cervical Neoplasia. Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, Desalle R, Befano B, Yu K, Safaeian M, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, Solomon D, Castle PE, Burk RD, Cancer Res 2010 70 3159 3169 10.1158/0008-5472. CAN-09-4179 20354192
13. Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis. Zehbe I, Richard C, DeCarlo CA, Shai A, Lambert PF, Lichtig H, Tommasino M, Sherman L, Virology 2009 383 69 77 10.1016/j.virol.2008.09.036 18986660
14. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Takeda N, Sakuragi N, Takeda M, Okamoto K, Kuwabara M, Negishi H, Oikawa M, Yamamoto R, Yamada H, Fujimoto S, Acta Obstet Gynecol Scand 2002 81 1144 1151 10.1034/j.1600-0412.2002.811208.x 12519111 (Pubitemid 35454363)
15. Prognostic Significance of Histology and Positive Lymph Node Involvement Following Radical Hysterectomy in Carcinoma of the Cervix. Macdonald OK, Chen J, Dodson M, Lee CM, Gaffney DK, Am J Clin Oncol 2009 32 411 416 10.1097/COC.0b013e31819142dc 19451800
16. Cervical Cancer. Hacker N, Practical Gynecologic Oncology Philadelphia PA: Lippincott Williams and Wilkins, Berek JS, 4 2005 337 395
17. An Analysis of Cell Type in Patients with Surgically Staged Stage IB Carcinoma of the Cervix: A Gynecologic Oncology Group Study. Look KY, Brunetto VL, Clarke-Pearson DL, Averette HE, Major FJ, Alvarez RD, Homesley HD, Zaino RJ, Gynecol Oncol 1996 63 304 311 10.1006/gyno.1996.0327 8946863 (Pubitemid 26408987)
18. Early Stage Cervical Cancers Containing Human Papillomavirus Type 18 DNA Have More Nodal Metastasis and Deeper Stromal Invasion. Im SS, Wilczynski SP, Burger RA, Monk BJ, Clin Cancer Res 2003 9 4145 4150 14519638 (Pubitemid 37204032)
19. Human Papillomavirus Cofactors by Disease Progression and Human Papillomavirus Types in the Study to Understand Cervical Cancer Early Endpoints and Determinants. Wang SS, Zuna RE, Wentzensen N, Dunn ST, Sherman ME, Gold MA, Schiffman M, Wacholder S, Allen RA, Block I, Downing K, Jeronimo J, Carreon JD, Safaeian M, Brown D, Walker JL, Cancer Epidemiol Biomarkers Prev 2009 18 113 120 10.1158/1055-9965.EPI-08-0591 19124488
20. Distribution of HPV genotypes in 282 women with cervical lesions: evidence for three categories of intraepithelial lesions based on morphology and HPV type. Zuna RE, Allen RA, Moore WE, Lu Y, Mattu R, Dunn ST, Mod Pathol 2007 20 167 174 10.1038/modpathol.3800723 17192793 (Pubitemid 46422170)
21. Tavassoli FA, Devilee P, Ed, Pathology and Genetics of Tumors of the Breast and Female Genital Organs Lyon: IARC Press 2003
22. Survival in cervical cancer with respect to cell type. Wentz WB, Reagan JW, Cancer 1959 12 384 388 10.1002/1097-0142(195903/04)12:2<384::AID- CNCR2820120222>3.0.CO;2-C 13638958
23. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Thompson JD, Higgins DG, Gibson TJ, Nucl Acids Res 1994 22 4673 4680 10.1093/nar/22.22.4673 7984417 (Pubitemid 24354800)
24. Human papillomavirus type 16 DNA sequence. Seedorf K, Krämmer G, Dürst M, Suhai S, Röwekamp WG, Virology 1985 145 181 185 10.1016/0042-6822(85)90214-4 2990099 (Pubitemid 15234421)
25. Myers G DH, Icenogle J, Bernard H-U, Baker A, Halpern A, Wheeler C, Human papillomaviruses: a compilation and analysis of nucleic acid and amino acid sequences Los Alamos, NM: Los Alamos National Laboratory 1995